Eiken Chemical Co Ltd
TSE:4549
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 644
2 552
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Eiken Chemical Co Ltd
Eiken Chemical Co Ltd
Cost of Revenue
Eiken Chemical Co Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Eiken Chemical Co Ltd
TSE:4549
|
Cost of Revenue
-¥23.2B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-3%
|
|
|
Hoya Corp
TSE:7741
|
Cost of Revenue
-¥112.1B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-2%
|
|
|
H
|
Hogy Medical Co Ltd
TSE:3593
|
Cost of Revenue
-¥33B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-7%
|
|
|
Menicon Co Ltd
TSE:7780
|
Cost of Revenue
-¥55.3B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
Mani Inc
TSE:7730
|
Cost of Revenue
-¥10.6B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-10%
|
|
|
Nipro Corp
TSE:8086
|
Cost of Revenue
-¥424.4B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-7%
|
|
Eiken Chemical Co Ltd
Glance View
Eiken Chemical Co., Ltd. engages in the manufacture and sale of clinical diagnostics products and equipment. The company is headquartered in Taito-Ku, Tokyo-To and currently employs 733 full-time employees. Through its subsidiaries, the Company involves in the processing, manufacture, purchase and sale of test agents. The products and services include microbial testing reagents, urine testing reagents, immunoserologic testing reagents, biochemical testing reagents and instrument food environment-related media.
See Also
What is Eiken Chemical Co Ltd's Cost of Revenue?
Cost of Revenue
-23.2B
JPY
Based on the financial report for Sep 30, 2024, Eiken Chemical Co Ltd's Cost of Revenue amounts to -23.2B JPY.
What is Eiken Chemical Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-3%
Over the last year, the Cost of Revenue growth was -1%. The average annual Cost of Revenue growth rates for Eiken Chemical Co Ltd have been -3% over the past three years , -2% over the past five years , and -3% over the past ten years .
You don't have any saved screeners yet
